AGILISIUM at AWS re:Invent 2024
Accelerate your AWS Cloud Modernization journey with Agilisium's Generative AI Solutions
Register nowOverview
AWS re:Invent 2024 brings together cloud enthusiasts, experts, and practitioners for the ultimate event in Cloud computing and Generative AI.
As an AWS Advanced Consulting Partner, join us to learn from our experts about the latest advancements in infrastructure, AI/ML, and the most recent trends and breakthroughs in Gen AI. Explore how these developments can drive your business forward. Keep an eye out for updates as we continue to share more interesting topics and new talks leading up to the event.
To improve the chance of getting individual drugs to market, biotech and pharma companies need to be able to analyze as much of the available data as possible. The right data will help companies to:
Join Our Track Session
Unleash LLMs to Progress from Bench to Bedside and Beyond
Track Name: LLMs, 17th September, 5:05 PM EST
In this session, we explore the pivotal role of Large Language Models (LLMs) and their proven top business use cases in transforming the landscape of translational medicine, accelerating the journey from Drug Discovery to Drug Commercialization. The session will also explore the exclusive “Strategic Framework for Generative AI Use Cases in Life Sciences”, focusing on how to overcome the key data challenges in the biopharma industry, such as Data Silos, Data Quality issues, and Data Demonetization, through our “NextGen AI-powered DataOps” solutions.
.png)
.png)
Track Name: LLMs, 17 th September, 5:05 PM EST
Visit us and engage with our business leaders and technical experts at Booth #503 to gain first-hand insights into our latest GenAI solutions, receive personalized demonstrations, and our Life Sciences business consultants will share case studies, highlighting successful applications of LLMs that benefit all stakeholders across the entire pharma value chain.Plus, it's a great way to network, ask questions, and stay ahead of industry trends.
Join us at AWS re:Invent 2024 for a first-hand look at Agilisium’s latest Gen AI solutions and live demos. Connect with our experts for an exclusive Gen AI framework & industry trends that redefines Pharma industry.
Industry Recognition
Agilisium Recognized as a Leader in Everest Group Life Sciences Digital Services for Mid-Market Enterprises PEAK Matrix® Report.
The Everest Group evaluated Agilisium’s capabilities across the Life Sciences value chain along with client case studies and references.
Agilisium Recognized as a Product Challenger in ISG Provider Lens™ Life Sciences and Healthcare Analytics Services — Specialist Providers 2024 study.
The ISG Group evaluated Agilisium’s expertise in enabling enterprises to improve decision-making utilizing AI and analytics.
Agilisium Recognized as a Product Challenger in ISG Provider Lens™ AWS Ecosystem Partners — Data Analytics, AI and ML Providers 2023 study.
The ISG Group evaluated Agilisium’s ability to utilize analytics and ML to convert data into insights, driving innovation and efficiency in client operations.
